Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$223M |
| 2 |
CVS Health
CVS
|
+$18.9M |
| 3 |
American International
AIG
|
+$16.3M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$13.4M |
| 5 |
TJX Companies
TJX
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$12.6M |
| 2 |
Crown Castle
CCI
|
+$7.91M |
| 3 |
Eli Lilly
LLY
|
+$7.58M |
| 4 |
RTX Corp
RTX
|
+$7.28M |
| 5 |
Deere & Co
DE
|
+$7.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.16% |
| 2 | Consumer Discretionary | 11.77% |
| 3 | Financials | 11.5% |
| 4 | Healthcare | 9.84% |
| 5 | Technology | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
Geron
GERN
$597M
| $140K | 0.01% |
+52,100
| New | +$152K |
2016 Q2
0 quarters
|
|
|
AREX
952
DELISTED
Approach Resources Inc.
AREX
| $140K | 0.01% |
+66,800
| New | +$151K |
2016 Q2
0 quarters
|
|
953
Century Aluminum
CENX
$3.32B
| $138K | 0.01% |
+21,836
| New | +$153K |
2016 Q2
0 quarters
|
|
954
DELISTED
Chimerix, Inc.
CMRX
| $137K | 0.01% |
+34,900
| New | +$172K |
2016 Q2
0 quarters
|
|
955
BGC Group
BGC
$5.24B
| $135K | 0.01% |
24,103
-22,858
| -49% | -$133K |
2015 Q4
2 quarters
|
|
956
Scorpio Tankers
STNG
$4.47B
| $131K | 0.01% |
+3,130
| New | +$175K |
2016 Q2
0 quarters
|
|
|
SNR
957
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $131K | 0.01% |
+12,227
| New | +$130K |
2016 Q2
0 quarters
|
|
|
BRCD
958
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $131K | 0.01% |
14,260
-61,740
| -81% | -$553K |
2015 Q3
3 quarters
|
|
|
KND
959
DELISTED
Kindred Healthcare
KND
| $128K | 0.01% |
11,302
-38,383
| -77% | -$481K |
2016 Q1
1 quarter
|
|
960
FNB Corp
FNB
$6.5B
| $127K | 0.01% |
10,147
-55,140
| -84% | -$714K |
2016 Q1
1 quarter
|
|
|
SCMP
961
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $127K | 0.01% |
+11,600
| New | +$130K |
2016 Q2
0 quarters
|
|
962
Standard BioTools
LAB
$243M
| $121K | 0.01% |
+13,400
| New | +$126K |
2016 Q2
0 quarters
|
|
963
DELISTED
LivePerson
LPSN
| $121K | 0.01% |
+1,267
| New | +$121K |
2016 Q2
0 quarters
|
|
|
NVTR
964
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $120K | 0.01% |
+16,199
| New | +$129K |
2016 Q2
0 quarters
|
|
|
NYRT
965
DELISTED
New York REIT, Inc.
NYRT
| $120K | 0.01% |
+1,300
| New | +$126K |
2016 Q2
0 quarters
|
|
|
NPTN
966
DELISTED
NEOPHOTONICS CORP
NPTN
| $118K | 0.01% |
12,422
-25,578
| -67% | -$278K |
2016 Q1
1 quarter
|
|
|
CBR
967
DELISTED
CIBER Inc.
CBR
| $118K | 0.01% |
+78,600
| New | +$134K |
2016 Q2
0 quarters
|
|
968
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $117K | 0.01% |
+17,600
| New | +$163K |
2016 Q2
0 quarters
|
|
|
MNTA
969
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $113K | 0.01% |
+10,419
| New | +$107K |
2016 Q2
0 quarters
|
|
|
TNGO
970
DELISTED
Tangoe, Inc.
TNGO
| $109K | 0.01% |
+14,105
| New | +$114K |
2016 Q2
0 quarters
|
|
971
Innoviva
INVA
$1.52B
| $108K | 0.01% |
10,300
-13,900
| -57% | -$164K |
2016 Q1
1 quarter
|
|
|
OMN
972
DELISTED
OMNOVA Solutions Inc.
OMN
| $107K | 0.01% |
+14,723
| New | +$99K |
2016 Q2
0 quarters
|
|
|
CASC
973
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $105K | 0.01% |
+18,533
| New | +$126K |
2016 Q2
0 quarters
|
|
|
BKMU
974
DELISTED
Bank Mutual Corp
BKMU
| $104K | 0.01% |
+13,551
| New | +$106K |
2016 Q2
0 quarters
|
|
975
Alaunos Therapeutics
TCRT
$4.4M
| $103K | 0.01% |
125
-368
| -75% | -$401K |
2015 Q4
2 quarters
|
|
Similar funds
Squarepoint's Q2 2016 Portfolio in Review
As of Q2 2016, Squarepoint held 1,549 positions worth $1.6B, up 24% from $1.29B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Squarepoint deployed $307M of net new capital in Q2 2016, opening 435 new positions and adding to 314 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Crown Castle, an estimated $7.91M trimmed.
- Squarepoint's largest Q2 2016 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
- Squarepoint added most to CVS Health in Q2 2016, an estimated $18.9M increase.
- Squarepoint's biggest Q2 2016 reduction was Crown Castle, cutting an estimated $7.91M.
- Squarepoint fully exited Chubb in Q2 2016, selling an estimated $12.6M.
- Squarepoint's ten largest holdings make up 23% of its $1.6B portfolio in Q2 2016.
- Squarepoint opened 435 new positions and closed 482 in Q2 2016.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $1.6B.
Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.